Home > Insider Trading > Filing (0001415889-24-023401)

Filing Details

Accession Number:: 0001415889-24-023401
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-13 18:56:11
Reporting Period:: 2024-09-11

Accepted Time:: 2024-09-13 18:56:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516551	Skye Bioscience Inc.	SKYE	Pharmaceutical Preparations (2834)	450692882

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1598549	J. Andrew Schwab	C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-09-11	214,556	$6.60	8,178,964	No	4	S	Indirect	By 5AM Ventures VII, L.P.
Common Stock	Disposition	2024-09-11	36,504	$6.60	1,681,685	No	4	S	Indirect	By 5AM Ventures II, L.P.
Common Stock	Disposition	2024-09-11	1,440	$6.60	66,356	No	4	S	Indirect	By 5AM Co-Investors II, L.P.
Common Stock	Disposition	2024-09-13	11,758	$6.06	8,167,206	No	4	S	Indirect	By 5AM Ventures VII, L.P.
Common Stock	Disposition	2024-09-13	2,000	$6.06	1,679,685	No	4	S	Indirect	By 5AM Ventures II, L.P.
Common Stock	Disposition	2024-09-13	79	$6.06	66,277	No	4	S	Indirect	By 5AM Co-Investors II, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By 5AM Ventures VII, L.P.
No	4	S	Indirect	By 5AM Ventures II, L.P.
No	4	S	Indirect	By 5AM Co-Investors II, L.P.
No	4	S	Indirect	By 5AM Ventures VII, L.P.
No	4	S	Indirect	By 5AM Ventures II, L.P.
No	4	S	Indirect	By 5AM Co-Investors II, L.P.

Footnotes

The securities are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The securities are directly held by 5AM Ventures II, L.P. ("Ventures II"). 5AM Partners II, LLC ("Partners II") is the sole general partner of Ventures II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The securities are directly held by 5AM Co-Investors II, L.P. ("Co-Investors II"). Partners II is the sole general partner of Co-Investors II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.05 to $6.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.